---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-272562"
form_type: "8-K"
ticker: "QTTB"
cik: "0001661998"
company_name: "Q32 Bio Inc."
filed_at: "2026-06-16T20:01:35+00:00"
generated_at: "2026-06-16T20:03:48.035739+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Q32 Bio stockholders elect Class II directors, ratify auditor, approve say-on-pay at 2026 annual meeting

## Summary
- Stockholders elected Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos as Class II directors for three-year terms ending 2029.
- Ratification of Ernst & Young as independent auditor for FY 2026 passed with 11,821,046 votes for, 7,909 against.
- Non-binding advisory vote on named executive officer compensation approved with 8,072,067 for, 400,598 against.
- Turnout was 75.71% (11,833,800 of 15,629,463 outstanding shares represented).

## SEC filing metadata
- accession: 0001193125-26-272562
- form_type: 8-K
- ticker: QTTB
- cik: 0001661998
- company_name: Q32 Bio Inc.
- filed_at: 2026-06-16T20:01:35+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661998/000119312526272562/0001193125-26-272562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661998/000119312526272562/d117360d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-272562
- JSON: https://secwatch.observer/filing/0001193125-26-272562.json
- Plain text: https://secwatch.observer/filing/0001193125-26-272562.txt

## Key facts
- Shareholder Votes
  Q32 Bio Inc. shareholders approved Election of Class II Directors: Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D..
  - Proposal: director election
  - Outcome: passed
  source text: Proposal No. 1 - Election of Class II Directors: The stockholders of the Company elected Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D., as Class II directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2029 and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661998/000119312526272562/0001193125-26-272562-index.htm
- Shareholder Votes
  Q32 Bio Inc. shareholders approved Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-12-31
  source text: Proposal No. 2 - Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026: The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661998/000119312526272562/0001193125-26-272562-index.htm
- Shareholder Votes
  Q32 Bio Inc. shareholders approved Non-Binding, Advisory Vote on the Compensation of the Company’s Named Executive Officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: Proposal No. 3 - Non-Binding, Advisory Vote on the Compensation of the Company’s Named Executive Officers: The stockholders of the Company approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661998/000119312526272562/0001193125-26-272562-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.